Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 19 2019

Full Issue

Stabilizing Influence Or False Promise? Success Stories Pour In About Addiction Medication But Hesitations Remain

Despite the fact that buprenorphine has changed the lives of those struggling with addiction, it still doesn't have widespread support. Some worry that the medication, an opiate itself, is just replacing one addiction with another. But as the opioid continues to devastate the country, more and more are embracing the recovery method.

The Associated Press: Walk-In Clinics For Opioid Addiction Offer Meds First, Fast

Every time she got out of jail, Jamie Cline started hustling again for heroin, driven by an addiction she didn’t understand. “You want to get clean so bad. You know something’s killing you and you can’t stop,” said the 33-year-old who used heroin for 10 years. This spring was different. While in a jail work-release program, she took a medication called buprenorphine. (12/18)

Meanwhile, in other news on the crisis —

Bloomberg: Kapoor Deserves 15 Years For Opioid-Crisis Role, U.S. Says 

John Kapoor should serve 15 years in prison for leading a racketeering conspiracy that helped fuel the national opioid crisis with bribes to boost prescriptions of a highly addictive painkiller, federal prosecutors said. Four other former executives at Insys Therapeutics Inc., who were convicted at trial along with Kapoor, the former chief executive officer, deserve prison terms ranging from six to 11 years, the U.S. said in a court filing on Wednesday. Kapoor, 76, was the first CEO convicted in a federal opioid trial. (Lawrence, 12/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF